Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia

G. Kannan, K. L. Gressitt, S. Yang, C. R. Stallings, E. Katsafanas, L. A. Schweinfurth, C. L.G. Savage, M. B. Adamos, K. M. Sweeney, A. E. Origoni, S. Khushalani, S. Bahn, F. M. Leweke, F. B. Dickerson, Robert H Yolken, Mikhail Pletnikov, Emily G Severance

Research output: Contribution to journalArticle

Abstract

Autoantibodies that bind the N-methyl-D-aspartate receptor (NMDAR) may underlie glutamate receptor hypofunction and related cognitive impairment found in schizophrenia. Exposure to neurotropic pathogens can foster an autoimmune-prone environment and drive systemic inflammation leading to endothelial barrier defects. In mouse model cohorts, we demonstrate that infection with the protozoan parasite, Toxoplasma gondii, caused sustained elevations of IgG class antibodies to the NMDAR in conjunction with compromised blood-gut and blood-brain barriers. In human cohorts, NMDAR IgG and markers of barrier permeability were significantly associated with T. gondii exposure in schizophrenia compared with controls and independently of antipsychotic medication. Combined T. gondii and NMDAR antibody seropositivity in schizophrenia resulted in higher degrees of cognitive impairment as measured by tests of delayed memory. These data underscore the necessity of disentangling the heterogeneous pathophysiology of schizophrenia so that relevant subsets eligible for NMDAR-related treatment can be identified. Our data aid to reconcile conflicting reports regarding a role of pathological NMDAR autoantibodies in this disorder.

Original languageEnglish (US)
Article numbere1186
JournalTranslational Psychiatry
Volume7
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

N-Methyl-D-Aspartate Receptors
Autoimmunity
Schizophrenia
Toxoplasma
Autoantibodies
Immunoglobulin G
Protozoan Infections
Repression (Psychology)
Immunoglobulin Isotypes
Glutamate Receptors
Blood-Brain Barrier
Antipsychotic Agents
Permeability
Parasites
Inflammation
Antibodies

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Kannan, G., Gressitt, K. L., Yang, S., Stallings, C. R., Katsafanas, E., Schweinfurth, L. A., ... Severance, E. G. (2017). Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia. Translational Psychiatry, 7(8), [e1186]. https://doi.org/10.1038/tp.2017.162

Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia. / Kannan, G.; Gressitt, K. L.; Yang, S.; Stallings, C. R.; Katsafanas, E.; Schweinfurth, L. A.; Savage, C. L.G.; Adamos, M. B.; Sweeney, K. M.; Origoni, A. E.; Khushalani, S.; Bahn, S.; Leweke, F. M.; Dickerson, F. B.; Yolken, Robert H; Pletnikov, Mikhail; Severance, Emily G.

In: Translational Psychiatry, Vol. 7, No. 8, e1186, 01.08.2017.

Research output: Contribution to journalArticle

Kannan, G, Gressitt, KL, Yang, S, Stallings, CR, Katsafanas, E, Schweinfurth, LA, Savage, CLG, Adamos, MB, Sweeney, KM, Origoni, AE, Khushalani, S, Bahn, S, Leweke, FM, Dickerson, FB, Yolken, RH, Pletnikov, M & Severance, EG 2017, 'Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia', Translational Psychiatry, vol. 7, no. 8, e1186. https://doi.org/10.1038/tp.2017.162
Kannan G, Gressitt KL, Yang S, Stallings CR, Katsafanas E, Schweinfurth LA et al. Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia. Translational Psychiatry. 2017 Aug 1;7(8). e1186. https://doi.org/10.1038/tp.2017.162
Kannan, G. ; Gressitt, K. L. ; Yang, S. ; Stallings, C. R. ; Katsafanas, E. ; Schweinfurth, L. A. ; Savage, C. L.G. ; Adamos, M. B. ; Sweeney, K. M. ; Origoni, A. E. ; Khushalani, S. ; Bahn, S. ; Leweke, F. M. ; Dickerson, F. B. ; Yolken, Robert H ; Pletnikov, Mikhail ; Severance, Emily G. / Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia. In: Translational Psychiatry. 2017 ; Vol. 7, No. 8.
@article{b7b53bfb6ff24428a1f322171334dbe0,
title = "Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia",
abstract = "Autoantibodies that bind the N-methyl-D-aspartate receptor (NMDAR) may underlie glutamate receptor hypofunction and related cognitive impairment found in schizophrenia. Exposure to neurotropic pathogens can foster an autoimmune-prone environment and drive systemic inflammation leading to endothelial barrier defects. In mouse model cohorts, we demonstrate that infection with the protozoan parasite, Toxoplasma gondii, caused sustained elevations of IgG class antibodies to the NMDAR in conjunction with compromised blood-gut and blood-brain barriers. In human cohorts, NMDAR IgG and markers of barrier permeability were significantly associated with T. gondii exposure in schizophrenia compared with controls and independently of antipsychotic medication. Combined T. gondii and NMDAR antibody seropositivity in schizophrenia resulted in higher degrees of cognitive impairment as measured by tests of delayed memory. These data underscore the necessity of disentangling the heterogeneous pathophysiology of schizophrenia so that relevant subsets eligible for NMDAR-related treatment can be identified. Our data aid to reconcile conflicting reports regarding a role of pathological NMDAR autoantibodies in this disorder.",
author = "G. Kannan and Gressitt, {K. L.} and S. Yang and Stallings, {C. R.} and E. Katsafanas and Schweinfurth, {L. A.} and Savage, {C. L.G.} and Adamos, {M. B.} and Sweeney, {K. M.} and Origoni, {A. E.} and S. Khushalani and S. Bahn and Leweke, {F. M.} and Dickerson, {F. B.} and Yolken, {Robert H} and Mikhail Pletnikov and Severance, {Emily G}",
year = "2017",
month = "8",
day = "1",
doi = "10.1038/tp.2017.162",
language = "English (US)",
volume = "7",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia

AU - Kannan, G.

AU - Gressitt, K. L.

AU - Yang, S.

AU - Stallings, C. R.

AU - Katsafanas, E.

AU - Schweinfurth, L. A.

AU - Savage, C. L.G.

AU - Adamos, M. B.

AU - Sweeney, K. M.

AU - Origoni, A. E.

AU - Khushalani, S.

AU - Bahn, S.

AU - Leweke, F. M.

AU - Dickerson, F. B.

AU - Yolken, Robert H

AU - Pletnikov, Mikhail

AU - Severance, Emily G

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Autoantibodies that bind the N-methyl-D-aspartate receptor (NMDAR) may underlie glutamate receptor hypofunction and related cognitive impairment found in schizophrenia. Exposure to neurotropic pathogens can foster an autoimmune-prone environment and drive systemic inflammation leading to endothelial barrier defects. In mouse model cohorts, we demonstrate that infection with the protozoan parasite, Toxoplasma gondii, caused sustained elevations of IgG class antibodies to the NMDAR in conjunction with compromised blood-gut and blood-brain barriers. In human cohorts, NMDAR IgG and markers of barrier permeability were significantly associated with T. gondii exposure in schizophrenia compared with controls and independently of antipsychotic medication. Combined T. gondii and NMDAR antibody seropositivity in schizophrenia resulted in higher degrees of cognitive impairment as measured by tests of delayed memory. These data underscore the necessity of disentangling the heterogeneous pathophysiology of schizophrenia so that relevant subsets eligible for NMDAR-related treatment can be identified. Our data aid to reconcile conflicting reports regarding a role of pathological NMDAR autoantibodies in this disorder.

AB - Autoantibodies that bind the N-methyl-D-aspartate receptor (NMDAR) may underlie glutamate receptor hypofunction and related cognitive impairment found in schizophrenia. Exposure to neurotropic pathogens can foster an autoimmune-prone environment and drive systemic inflammation leading to endothelial barrier defects. In mouse model cohorts, we demonstrate that infection with the protozoan parasite, Toxoplasma gondii, caused sustained elevations of IgG class antibodies to the NMDAR in conjunction with compromised blood-gut and blood-brain barriers. In human cohorts, NMDAR IgG and markers of barrier permeability were significantly associated with T. gondii exposure in schizophrenia compared with controls and independently of antipsychotic medication. Combined T. gondii and NMDAR antibody seropositivity in schizophrenia resulted in higher degrees of cognitive impairment as measured by tests of delayed memory. These data underscore the necessity of disentangling the heterogeneous pathophysiology of schizophrenia so that relevant subsets eligible for NMDAR-related treatment can be identified. Our data aid to reconcile conflicting reports regarding a role of pathological NMDAR autoantibodies in this disorder.

UR - http://www.scopus.com/inward/record.url?scp=85026748536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026748536&partnerID=8YFLogxK

U2 - 10.1038/tp.2017.162

DO - 10.1038/tp.2017.162

M3 - Article

C2 - 28763062

AN - SCOPUS:85026748536

VL - 7

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

IS - 8

M1 - e1186

ER -